These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 30829606)
1. [A COMPARATIVE ANALYSIS OF THE DISPERSION QUALITY OF NASAL SPRAYS OXYMETAZOLINE]. Yankova V; Udyanskaya I; Slonskaya T; Plakhotnaya O; Gogokhia T Georgian Med News; 2019 Jan; (286):136-140. PubMed ID: 30829606 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist®) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging. Pritchard S; Glover M; Guthrie G; Brum J; Ramsey D; Kappler G; Thomas P; Stuart S; Hull D; Gowland P Pulm Pharmacol Ther; 2014 Feb; 27(1):121-6. PubMed ID: 23988443 [TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetics of an Intranasally Administered Combination of Oxymetazoline and Tetracaine in Healthy Volunteers. Cacek AT; Gobburu JV; Gopalakrishnan M J Clin Pharmacol; 2017 Feb; 57(2):247-254. PubMed ID: 27436060 [TBL] [Abstract][Full Text] [Related]
7. A new nasal decongestant, A-57219: a comparison with oxymetazoline. DeBernardis JF; Winn M; Kerkman DJ; Kyncl JJ; Buckner S; Horrom B J Pharm Pharmacol; 1987 Sep; 39(9):760-3. PubMed ID: 2445950 [TBL] [Abstract][Full Text] [Related]
8. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Graf P; Hallén H Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089 [TBL] [Abstract][Full Text] [Related]
9. Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray. Rajpal S; Morris LA; Akkus NI Rev Port Cardiol; 2014 Jan; 33(1):51.e1-4. PubMed ID: 24405558 [TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of nasal blood flow and airflow in the decongestant response to oxymetazoline. Vaidyanathan S; Williamson P; Lipworth B Ann Allergy Asthma Immunol; 2012 Feb; 108(2):77-80. PubMed ID: 22289724 [TBL] [Abstract][Full Text] [Related]
12. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis. Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657 [TBL] [Abstract][Full Text] [Related]
13. Effects of oxymetazoline nasal spray on the nasal cycle assessed by long-term rhinoflowmetry. Braun T; Rich M; Berghaus A; Kramer MF Rhinology; 2012 Dec; 50(4):370-5. PubMed ID: 23181250 [TBL] [Abstract][Full Text] [Related]
17. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers. Hallén H; Graf P Clin Exp Allergy; 1995 May; 25(5):401-5. PubMed ID: 7553242 [TBL] [Abstract][Full Text] [Related]
18. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa. Ferguson BJ; Paramaesvaran S; Rubinstein E Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762 [TBL] [Abstract][Full Text] [Related]
19. [The observation of the ciliotoxicity of nasal mucosa with nasal decongestant]. Teng Y; Zhang X; Xu G; Cai Q; Xu J Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Sep; 19(18):824-6. PubMed ID: 16375111 [TBL] [Abstract][Full Text] [Related]
20. Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method. Kundoor V; Dalby RN Pharm Res; 2010 Jan; 27(1):30-6. PubMed ID: 19902337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]